•  

Browse and digest the latest news in neurosurgery

Message from NEUROSURGIC

Please observe that

we do not have the possibilty to

add more conferences

for the moment

 
News_210x100.jpg

Neurosurgical news

Keep yourself updated by browsing our news!

Select a news category from the menu to the right! For the latest news - login and go to the Startpage.

ROSA.jpgROSA - Stereotactic Neurological Surgery Robot

Medtech (Montpellier, France) has developed ROSA™, a stereotactic robot intended for needle-based intracranial procedures like biopsies, epilepsy surgeries, and tumor resections, and features “a neurosurgical planning software, navigation and advanced robotic functions, haptic technology and advanced visualization capabilities.

According to the product brochure ROSA™ offers intuitive and powerful planning capabilities, surgeon oriented ergonomics, precise and dexterous instrument guidance, and haptic collaboration with surgeon.

Read more on MedGadget.

Read more Medtech.

Mazor.jpgMazor’s New Renaissance Robotic Spinal Surgery System

In a Press Release Israeli Mazor Robotics unveils its new Renaissance spinal robotic surgical guidance system. The device takes advantage of the same technology inside Mazor’s SpineAssist , but improves on usability through new hardware and software.  The Renaissance system has already received both FDA clearance and EU’s CE Mark of approval.

According to the Product Page Mazor Robotics’ Renaissance™ is transforming spine surgery from freehand procedures to highly-accurate, state-of-the-art robotic procedures, with less radiation - even for minimally invasive surgery (MIS), scoliosis, and other complex spinal deformity cases. 

Read more on MedGadget.

Read more in Press Release.

TNS.jpgTrigeminal Nerve Stimulation for Epilepsy Management

News Release from UCLA reports about promising results of a phase 2 clinical trial of trigeminal nerve stimulation (TNS) for controlling drug resistant epilepsy. Professor DeGiorgio, a lead inventor of the technology, reports that the latest trial has shown that 40% of patients treated with the system had a significant reduction in seizure frequency.

The external stimulator attaches to a belt or can slip into a pocket. Wires from the stimulator are connected to conductive pads attached to the forehead. The electrodes transmit a signal to the trigeminal nerve, which extends into the brain from the face and forehead and is known to play a role in seizure inhibition.

Read more on MedGadget.

Kelyniam.jpgKelyniam Custom Cranial Implants get FDA clearance

In a Press Relase Kelynam, CT, USA, reports that their Patient Specific Custom Skull Implants have received clearance from the U.S. Food andDrug Administration (FDA).

Based on the patient CT scan, Kelyniam manufactures an individual skull implant, with a turn around time of 24 h from receipt of CT scans. The implant is built using PEEK-OPTIMA polymer, which is lightweight, radiolucent and autoclavable.

Read more on MedGadget.

Read more in brochure from Kelyniam.

NovoTTF.jpgNovoTTF-100A for Treatment of Brain Tumors Wins FDA Clearance

NovoTTF-100A, a device for treatment of glioblastoma multiforme from Novocure, received FDA approval following a clinical trial and an agency panel recommendation. The device creates an electric field at the tumor site, preventing cancer cells from dividing and the tumor from growing. The system is indicated for patients following tumor recurrence after receiving chemotherapy.

According to a study of 237 subjects patients treated with the NovoTTF alone achieved a comparable overall survival time to patients treated with the physician's choice of the best chemotherapy. The rate of progression free survival at six months (PFS6) was 21 percent in the NovoTTF group compared to 15 percent in chemotherapy patients.

Read more on MedGadget.

Page 3 of 11

You are here: